EE200000270A - Escherichia coli tüve DSM 6601 kasutamine ravimite valmistamiseks - Google Patents

Escherichia coli tüve DSM 6601 kasutamine ravimite valmistamiseks

Info

Publication number
EE200000270A
EE200000270A EEP200000270A EEP200000270A EE200000270A EE 200000270 A EE200000270 A EE 200000270A EE P200000270 A EEP200000270 A EE P200000270A EE P200000270 A EEP200000270 A EE P200000270A EE 200000270 A EE200000270 A EE 200000270A
Authority
EE
Estonia
Prior art keywords
escherichia coli
coli strain
medicament
manufacture
strain dsm
Prior art date
Application number
EEP200000270A
Other languages
English (en)
Inventor
Proppert Hans
Original Assignee
Pharma-Zentrale Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma-Zentrale Gmbh filed Critical Pharma-Zentrale Gmbh
Publication of EE200000270A publication Critical patent/EE200000270A/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EEP200000270A 1997-11-22 1998-11-18 Escherichia coli tüve DSM 6601 kasutamine ravimite valmistamiseks EE200000270A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19751907A DE19751907B4 (de) 1997-11-22 1997-11-22 Verwendung von Escherichia coli Stamm DSM 6601 zur Behandlung von Diarrhoeen auf dem Veterinärsektor
PCT/EP1998/007389 WO1999026642A1 (de) 1997-11-22 1998-11-18 Verwendung von escherichia coli stamm dsm 6601 zur behandlung von diarrhoeen auf dem veterinärsektor

Publications (1)

Publication Number Publication Date
EE200000270A true EE200000270A (et) 2001-08-15

Family

ID=7849590

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000270A EE200000270A (et) 1997-11-22 1998-11-18 Escherichia coli tüve DSM 6601 kasutamine ravimite valmistamiseks

Country Status (14)

Country Link
EP (1) EP1033993B1 (et)
JP (1) JP2001523726A (et)
AT (1) ATE206617T1 (et)
CZ (1) CZ290100B6 (et)
DE (2) DE19751907B4 (et)
DK (1) DK1033993T3 (et)
EE (1) EE200000270A (et)
ES (1) ES2165709T3 (et)
HK (1) HK1031996A1 (et)
HU (1) HUP0004366A3 (et)
NO (1) NO20002577L (et)
PL (1) PL340328A1 (et)
PT (1) PT1033993E (et)
WO (1) WO1999026642A1 (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10328669B4 (de) * 2003-06-26 2005-12-01 Pharma-Zentrale Gmbh Plasmidfreier Klon des E. coli Stammes DSM 6601
KR20060073937A (ko) * 2003-08-18 2006-06-29 더 바이오 밸런스 코포레이션 안정한 액상 촉생제 조성물, 그의 제조 및 응용

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
DE19637936A1 (de) * 1996-09-17 1998-04-09 Lehr Claus Michael Prof Dr Arzneistoffzubereitung mit natürlicher bioadhäsiver Komponente
AUPO430496A0 (en) * 1996-12-19 1997-01-23 Arnott's Biscuits Limited Prebiotics and probiotics

Also Published As

Publication number Publication date
DK1033993T3 (da) 2002-01-28
DE19751907B4 (de) 2004-07-08
ATE206617T1 (de) 2001-10-15
WO1999026642A1 (de) 1999-06-03
CZ20001894A3 (cs) 2000-11-15
HK1031996A1 (en) 2001-07-06
ES2165709T3 (es) 2002-03-16
HUP0004366A3 (en) 2001-09-28
DE59801718D1 (de) 2001-11-15
EP1033993A1 (de) 2000-09-13
NO20002577D0 (no) 2000-05-19
HUP0004366A2 (hu) 2001-04-28
CZ290100B6 (cs) 2002-05-15
DE19751907A1 (de) 1999-07-29
NO20002577L (no) 2000-07-18
PL340328A1 (en) 2001-01-29
JP2001523726A (ja) 2001-11-27
EP1033993B1 (de) 2001-10-10
PT1033993E (pt) 2002-03-28

Similar Documents

Publication Publication Date Title
EP0713493A4 (en) PRODUCTION OF HUMAN HEMOGLOBIN IN TRANSGENIC PIGS
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
CA2168963A1 (en) Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases
IL122248A0 (en) Use of nisin for treating an infection
FI963232A0 (fi) Antimikrobisena aineena käytettävä hapotettu nitriitti
NZ332721A (en) Use of bactericidal/permeability increasing (BPI) protein sometimes in conjunction with a thrombolytic agent to treat thrombotic disorders
PL310474A1 (en) Application of rilusole in treating neuro-aids diseases
BG101040A (en) Benzopyrans and their use as therapeutic agents
GB9425730D0 (en) Compounds
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
BG102667A (en) Diosgenine-containing composition
EE200000270A (et) Escherichia coli tüve DSM 6601 kasutamine ravimite valmistamiseks
WO2002053149A3 (de) Arzneimittel enthaltend ein polyamin als wirksubstanz
AU1278600A (en) Novel therapeutic application of nicergoline
HUP0100608A2 (hu) Baktericid és fungicid hatású N-(3-klór-4-metil-fenil)-4-metil-1,2,3-tiadiazol-5-karboxamid, ezt tartalmazó növényvédő szer és alkalmazása
BG104259A (en) Derivatives of 4-cyano-4-deformylsordaricin
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
MD980129A (en) Antiherpetic remedy
GB8829935D0 (en) Fungicidal compounds,their production and use
AU2177401A (en) Combination of riluzole and gabapentin and use thereof as medicine
IT1216096B (it) L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.
BR0007491A (pt) Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções
AU1278700A (en) Novel therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline